1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS

Indoco Remedies Ltd.

NSE: INDOCO | BSE: 532612

Mid-range Performer

Check Buy or Sell

400.20 -16.50 (-3.96%)

46.11% Gain from 52W Low

96,124 NSE+BSE Volume

NSE Jan 24, 2022 03:31 PM

Watchlist

Portfolio

Alert

Share
17S
6W
4O
5T
1,411

Operating Revenue TTM Cr

Below industry Median
131.7

Net profit TTM Cr

Below industry Median
9.3

Net Profit Margin TTM %

Below industry Median
21.1

Revenue Growth (TTM)

Above industry Median
130.5

Profit Growth (TTM)

High in industry


Documents
02 Nov, 2021 TRENDLYNE
Earnings Call for Q2FY22 of Indoco Remedies
Earnings Call for Q2FY22 of Indoco Remedies
video link
11 Aug, 2021 TRENDLYNE
Earnings Call for Q1FY22 of Indoco Remedies
Earnings Call for Q1FY22 of Indoco Remedies
video link
04 Jun, 2021 BSE INDIA
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings…
Indoco Remedies Ltd - 532612 - Announcement under Regulation 30 (LODR)-Earnings…
pdf link
25 May, 2021 TRENDLYNE
Earnings Call for Q4FY21 of Indoco Remedies
Earnings Call for Q4FY21 of Indoco Remedies
video link
11 Aug, 2020 TRENDLYNE
Earnings Call Transcript - Q1FY21 for Indoco Remedies
Earnings Call Transcript - Q1FY21 for Indoco Remedies
link
24 Jun, 2020 TRENDLYNE
Earnings Call Transcript - Q4FY20 for Indoco Remedies
Earnings Call Transcript - Q4FY20 for Indoco Remedies
link
All Earnings Calls
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
Annual Report Mar-2011
pdf
Annual Report Mar-2010
pdf